The first of two papers coming out from the Movember GAP1 Urine Biomarker Consortium looking at how epigenetics can...

The first of two papers coming out from the Movember GAP1 Urine Biomarker Consortium looking at how epigenetics can be used to identify clinically significant prostate cancer. I contributed some analyses and advice to this one. More exciting stuff coming soon from this project.

Movember Foundation
https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-018-0575-z

Comments

Popular posts from this blog

Nationwide statement to QIF Format

Search down those house prices